Correspondence 0001628280-24-023490 from Skye Bioscience, Inc. (SKYE) (CIK 0001516551) (SKYE)
Skye Bioscience, Inc. (SKYE) (CIK 0001516551)
Date: May 15, 2024 · CIK: 0001516551 · Accession: 0001628280-24-023490
AI Filing Summary & Sentiment
File numbers found in text: 333-279330
Letter
VIA EDGAR Division of Corporation Finance Attention: Dan Crawford Re: Skye Bioscience, Inc. Registration Statement on Form S-3 (File No. 333-279330) Request for Acceleration
Dear Mr. Crawford:
Pursuant to Rule 461 of the General Rules and Regulations of the Securities and Exchange Commission promulgated under the Securities Act of 1933, as amended, Skye Bioscience, Inc. hereby requests that the effective date of the above-captioned Registration Statement on Form S-3 be accelerated to 4:15 p.m., Eastern Time, on May 17, 2024, or as soon as practicable thereafter. This request is being filed to correct a prior request that the effective date of the above-captioned Registration Statement on Form S-3 be accelerated to 4:15 p.m., Eastern Time, on April 17, 2024, or as soon as practicable thereafter.
Please contact John Hensley of Morrison & Foerster LLP via telephone at (512) 617-0661 or via e-mail at JHensley@mofo.com with any questions you may have. In addition, please notify Mr. Hensley when this request for acceleration has been granted.
Sincerely,
Skye Bioscience, Inc.
Show Raw Text
CORRESP 1 filename1.htm Document Skye Bioscience, Inc. 11250 El Camino Real, Suite 100 San Diego, CA 92130 May 15, 2024 VIA EDGAR U.S. Securities and Exchange Commission Division of Corporation Finance 100 F Street, N.E. Washington, D.C. 20549-3720 Attention: Dan Crawford Re: Skye Bioscience, Inc. Registration Statement on Form S-3 (File No. 333-279330) Request for Acceleration Dear Mr. Crawford: Pursuant to Rule 461 of the General Rules and Regulations of the Securities and Exchange Commission promulgated under the Securities Act of 1933, as amended, Skye Bioscience, Inc. hereby requests that the effective date of the above-captioned Registration Statement on Form S-3 be accelerated to 4:15 p.m., Eastern Time, on May 17, 2024, or as soon as practicable thereafter. This request is being filed to correct a prior request that the effective date of the above-captioned Registration Statement on Form S-3 be accelerated to 4:15 p.m., Eastern Time, on April 17, 2024, or as soon as practicable thereafter. Please contact John Hensley of Morrison & Foerster LLP via telephone at (512) 617-0661 or via e-mail at JHensley@mofo.com with any questions you may have. In addition, please notify Mr. Hensley when this request for acceleration has been granted. Sincerely, Skye Bioscience, Inc. /s/ Punit Dhillon Name: Punit Dhillon Title: Chief Executive Officer cc: Kaitlyn Arsenault, Chief Financial Officer R. John Hensley